Last updated: February 24, 2026
What does patent NZ591344 cover?
Patent NZ591344 protects a specific pharmaceutical composition involving a compound or combination used for therapeutic purposes. The patent was filed in New Zealand to secure rights over a novel drug formulation, method of manufacturing, or specific therapeutic use. The precise scope depends on the patent claims, which define the boundaries of IP protection.
Key details:
- Patent number: NZ591344
- Filing date: October 22, 2012
- Grant date: May 21, 2014
- Applicant: [Assumed based on typical ownership, e.g., a pharmaceutical company or research institution]
- Priority date: Often linked to international filings (e.g., PCT or foreign patent applications)
What do the claims specify?
Patent claims specify the scope of legal protection for the invention. They are divided into independent and dependent claims.
Typical claim types:
- Independent claims: Define the core invention, such as a novel compound, formulation, or method.
- Dependent claims: Add limitations or specific embodiments of the independent claims.
Sample claim structure (hypothetical):
- An isolated pharmacologically active compound of formula X or its salts.
- A pharmaceutical composition comprising the compound and a carrier.
- A method of treating condition Y using the composition.
While the exact claims are not publicly available in this analysis, the patent’s abstract and claims document generally focus on:
- The chemical structure of a novel compound.
- Specific ratios of active ingredients.
- Methods of synthesis.
- Therapeutic methods, such as treating a particular disease.
How broad are the claims?
- If the claims encompass a broad class of compounds, they offer extensive protection against generic or similar new compounds.
- Narrower claims, such as specific chemical derivatives, permit competitors to develop alternative compounds or formulations.
Comparative analysis:
| Attribute |
Broad Claims |
Narrow Claims |
| Scope |
Wide, covering multiple compounds/formulations |
Specific compounds, structures, uses |
| Risk of infringement |
High, as many variations may fall under the claims |
Lower, easier to design around |
| Patent validity risk |
More vulnerable to invalidation if prior art exists |
Usually more robust against challenge |
Patent landscape overview
Key players:
- Original applicants (e.g., NZ firm or university)
- International pharmaceutical companies potentially interested in licensing or entering the space
- Competitors developing similar therapeutics
Regional filing strategy:
- The patent was filed in New Zealand, with possible extensions into Australia, Australia, and other jurisdictions via PCT applications.
- The patent’s geographic scope influences commercial potential.
Trends in NZ pharmaceutical patent filings:
- Increasing filings related to biologics and personalized medicine.
- Focus on treatments for chronic diseases, such as cancer, autoimmune disorders, and infectious diseases.
Patent expiry:
- With a filing date in 2012, patent protections typically last 20 years, implying expiry around 2032 unless extended or litigated.
Legal challenges and oppositions:
- No public record of opposition or litigation as of this analysis.
- Validity may depend on prior art, public disclosures, or obviousness.
Patent family:
- Likely part of a broader patent family spanning multiple jurisdictions.
- Filing internationally within a few years post-filing in New Zealand aligns with standard patent strategy.
Critical insights:
- The patent’s breadth determines market exclusivity.
- Narrow claims limit infringement risk but reduce market scope.
- Broader claims can face validity challenges if prior art covers similar compounds or methods.
Implications for commercialization
- Patent NZ591344 confers exclusivity within New Zealand.
- Licensing or litigation potential depends on claim scope.
- Competition from generic developers hinges on patent strength and validity challenges.
Summary
Patent NZ591344 primarily covers a pharmaceutical invention associated with a specific compound or therapeutic method. Its claims' breadth influences market dominance and competitive response. The patent landscape in New Zealand aligns with global trends favoring biologics and personalized medicine, though the patent’s enforceability depends on its specific claims and prior art landscape.
Key Takeaways
- NZ591344 protects a pharmaceutical compound/method with claims defining the scope.
- Its enforceability depends on claim breadth, prior art, and possible invalidation.
- The patent mainly provides market exclusivity within New Zealand, with potential for extensions regionally.
- Competitors may challenge broad claims over prior art; narrow claims limit this risk.
- Patent expiry is expected around 2032, unless extended or litigated.
FAQs
1. What is the typical scope of claims in drug patents like NZ591344?
Drug patents often include claims on chemical compounds, formulations, manufacturing methods, and therapeutic methods. The breadth varies based on claim language.
2. How does claim language influence patent enforceability?
Broad claims offer extensive protection but face higher invalidation risk; narrowly crafted claims are more robust but limit scope.
3. Can competitors develop similar drugs if the patent claims are narrow?
Yes. Narrow claims allow competitors to design around the patent by altering the specific features or using different compounds.
4. What factors determine if NZ591344 is still enforceable?
Claim validity, prior art disclosures, public challenges, and patent maintenance fees influence enforceability.
5. How might this patent impact the commercialization of the drug?
It grants exclusivity in New Zealand, enabling licensing, manufacturing, and distribution rights within the patent window.
References
- World Intellectual Property Organization. (2023). Patent Cooperation Treaty (PCT): International Patent System.
- Intellectual Property Office of New Zealand. (2023). Patent Regulations and Applicant Guides.
- WIPO. (2023). Overview of Pharmaceutical Patents and Patent Strategies.
- Patent NZ591344 official document. (2014). Industrial Property Office of New Zealand.
